Abstract
Niraparib (Zejula (R)), a poly (ADP-ribose) polymerase (PARP) inhibitor, is approved for the maintenance treatment of recurrent, epithelial ovarian, f......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
